Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Xiaofang Bian
Special MTA: None
ATGACTCCGGCTGACGCGGACGAGGAACAGCGGGTGTCCTCGGTGCCCGTGTATCGGTGC
CGGCCAGGTAGGATTCCGAGCCGCGGCGCGGAAACCGAGACGGAGGAATCGTCGGCAGAG
GCCGTCGCTGATACTACCGGGGGAGATGACAGCGAGCTCGAGGAAGGGCCGCTGCCCGGG
GGTGACAAGGAAGCGTCCGCTGAAAATACCAACGTGTCGAGCGGCGTAGCGTGTGTAGCG
GGTTTTACGAGTGGTGGCGGCGTCGTCAGTTGGCGTCCCGAGTCGCCGTCTCCCGACGGC
ACGCCGTCTGTGCTGTCGTTGACGCGTGATAGCGGTCCCGCCGTGCCCAGTCGTGGTGGA
CGCGTGAGTAGCGGTCTGAGCACCTTCAATCCGACCGGCGCGACCAGGATGGAGCTGGAC
AGTGTCGAGGAGGAGGACGATTTCGGGGCTTCGCTCTGCAAAGTATCGCCGCCGATACAA
GCTACGCGCATGTTGATGGGCAAAAAGTGTCATTGTCACGGCTACTGGGGCAAGTTTCGC
TTTTGCGGCGTACAGGAGCCGGCGCGGGAGCTGCCGTCCGACAGGAACGCGCTGTGGCGC
GAGATGGACACCGTGTCGCGGCACAGTGCCGGTTTGGGCAGTTTCAGGCTATTTCAGCTC
ATTATGCGCCACGGTCCCTGTCTGATTCGTCACTCGCCGCGTTGCGACCTGCTGTTGGGT
CGCTTTTATTTCAAAGCCAACTGGGCGCGTGAAAGCCGCACGCCACTGTGTTACGCTTCG
GAGCTGTGCGATGAGTCGGTGCGCCGTTTTGTGCTGCGTCACATGGAGGATCTACCCAAG
CTGGCCGAGGAGACGGCGCGTTTTGTGGAATTGGCCGGTTGCTGGGGCTTGTACGCGGCC
ATTTTGTGTTTGGATAAGGTGTGTCGCCAACTGCACGGACAGGACGAGAGCCCGGGCGGC
GTGTTTTTGCGCATCGCCGTGGCGTTGACGGCCGCTATCGAGAACAGTAGGCACTCGCGC
ATCTATCGTTTCCATCTGGATGCGCGTTTCGAGGGCGAGGTGTTGGAATCGGTGTTGAAG
CGCTGTCGCGATGGGCAGCTGTCGCTGTCCACCTTCACCATGTCTACCGTGGGTTTCGAT
CGCGTGCCGCAGTACGACTTTCTGATCTCGGCCGACCCTTTCTCGCGTGACGCCAGTTGG
GCGGCCATGTGCAAGTGGATGAGTACCTTGAGTTGCGGCGTTTCTGTGTCGGTGAACGTA
ACGCGACTTAACGCCGATGTGAACAGCGTGATTCGTTGCCTGGGGGGATACTGCGATTTG
ATACGCGAGAAGGAGGTGCATCGACCCGTGGTACGTGTGTTTGTGGACATGTGGGACGTG
GCCGCTATCCGCGTGATTAACTTTATTCTCAAAGAAAGCACGTCGGAGTTGACGGGGGTT
TGCTACGCTTTCAACGTGCCTAGCGTGTTAATGAAGCGCTACCGTGCGCGTGAGCAGCGC
TACTCGCTGTTTGGGCGGCCTGTCTCCCGGCGGCTCTCGGACCTGGGTCAGGAGTCGGCT
TTCGAGAAAGAGTATTCGCGCTGCGAGCAATCGTGCCCCAAGGTGGTCGTGAACACGGAC
GATTTTCTGAAAAAGATGTTGCTGTGCGCGCTCAAGGGCCGTGCCTCGGTGGTCTTTGTC
CATCACGTAGTCAAGTACTCGATTATGGCCGACAGCGTGTGCCTGCCGCCGTGCTTGAGT
CCCGATATGGCGTCGTGCCACTTTGGCGAGTGTGACATGCCGGTGCAGCGGCTGACGGTG
AACGTGGCTCGCTGCGTGTTTGCGCGTAGCGACGAGCAGAAGCTGCATCTACCCGACGTG
GTTTTGGGGAACACGCGACGTTACTTTGATTTGAGCGTGCTGCGCGAGTTGGTGACCGAG
GCGGTGGTTTGGGGCAACGCGCGCTTGGACGCGCTAATGTCGGCGTCCGAATGGTGGGTA
GAGAGCGCGCTGGAAAAACTGCGTCCGCTGCACATCGGCGTGGCTGGCTTGCACACGGCG
CTCATGCGGTTAGGGTTCACGTACTTTGCCTCTTGGGACTTGATCGAGCGCATCTTTGAG
CACATGTACTTTGCCGCGGTGCGCGCTAGCGTCGATTTGTGCAAGTCGGGTTTGCCGCGC
TGCGAGTGGTTCGAACGCACCATCTATCAAGAGGGCAAATTCATTTTCGAATTGTATCGG
TTGCCGCGGCTCTCCATCGCCAGCGCGCGCTGGGAAGCGCTGCGCGCCGACATGCTCGAG
TTCGGATTGCGCAACTGTCAGTTTCTGGCGGTGGGTCCCGACGACGAGGTGGCGCATCTG
TGGGGCGTGACGCCGTCAGTGTGGGCTTCGCGCGGCACCGTGTTCGAGGAGGAGACGGTG
TGGTCATTGTGCCCGCCCAACCGTGAGTGTTACTTCCCCACCGTGGTGCGGAGGCCGCTG
CGCGTGCCCGTGGTGAATTACGCGTGGTTGGAGCAGCACCAGGAGGAGGGCAAGGCGACG
CAGTGTCTGTTCCAGGCGGCACCGGCGATCCAAAACGACGTGGAAATGGCGGCCGTGAAC
CTGAGCGTGTTTGTGGACCAGTGCGTGGCCCTGGTTTTCTACTATGACTCGGGGATGACG
CCCGACGTGCTTCTGGCCAGGATGCTCAAGTGGTACCACTGGCGCTTTAAGGTCGGAGTA
TATAAGTACTGTGCCTCT
MTPADADEEQRVSSVPVYRCRPGRIPSRGAETETEESSAEAVADTTGGDDSELEEGPLPG GDKEASAENTNVSSGVACVAGFTSGGGVVSWRPESPSPDGTPSVLSLTRDSGPAVPSRGG RVSSGLSTFNPTGATRMELDSVEEEDDFGASLCKVSPPIQATRMLMGKKCHCHGYWGKFR FCGVQEPARELPSDRNALWREMDTVSRHSAGLGSFRLFQLIMRHGPCLIRHSPRCDLLLG RFYFKANWARESRTPLCYASELCDESVRRFVLRHMEDLPKLAEETARFVELAGCWGLYAA ILCLDKVCRQLHGQDESPGGVFLRIAVALTAAIENSRHSRIYRFHLDARFEGEVLESVLK RCRDGQLSLSTFTMSTVGFDRVPQYDFLISADPFSRDASWAAMCKWMSTLSCGVSVSVNV TRLNADVNSVIRCLGGYCDLIREKEVHRPVVRVFVDMWDVAAIRVINFILKESTSELTGV CYAFNVPSVLMKRYRAREQRYSLFGRPVSRRLSDLGQESAFEKEYSRCEQSCPKVVVNTD DFLKKMLLCALKGRASVVFVHHVVKYSIMADSVCLPPCLSPDMASCHFGECDMPVQRLTV NVARCVFARSDEQKLHLPDVVLGNTRRYFDLSVLRELVTEAVVWGNARLDALMSASEWWV ESALEKLRPLHIGVAGLHTALMRLGFTYFASWDLIERIFEHMYFAAVRASVDLCKSGLPR CEWFERTIYQEGKFIFELYRLPRLSIASARWEALRADMLEFGLRNCQFLAVGPDDEVAHL WGVTPSVWASRGTVFEEETVWSLCPPNRECYFPTVVRRPLRVPVVNYAWLEQHQEEGKAT QCLFQAAPAIQNDVEMAAVNLSVFVDQCVALVFYYDSGMTPDVLLARMLKWYHWRFKVGV YKYCAS
Coding Sequence Details
Recommended Growth Condition: